keyword
https://read.qxmd.com/read/38644277/-establishment-of-a-prognostic-nomogram-and-discussion-on-optimal-treatment-for-cervical-adenocarcinoma-a-retrospective-study-based-on-seer-database-and-chinese-single-center-data
#1
JOURNAL ARTICLE
X Li, Y H Gao, Z Yang, Y Ma, C Liu, G C Liu, D B Wang
Objective: To establish and validate a predicting nomogram for cervical adenocarcinoma based on surveillance, epidemiology and end results (SEER) database and Chinese single-center data, and to explore the optimal treatment for cervical adenocarcinoma. Methods: This study selected 2 478 cervical adenocarcinoma patients from the SEER database as the training cohort, and 195 cervical adenocarcinoma patients from Cancer Hospital of Dalian University of Technology, Liaouing Cancer Hospital and Institute as an external validation cohort...
April 25, 2024: Zhonghua Fu Chan Ke za Zhi
https://read.qxmd.com/read/38637579/development-and-validation-of-a-nomogram-to-predict-cancer-specific-survival-of-elderly-patients-with-unresected-gastric-cancer-who-received-chemotherapy
#2
JOURNAL ARTICLE
Qi Wang, Kexin Shen, Bingyuan Fei, Mengqiang Wei, Xinbin Ge, Zhongshi Xie
This investigation aimed to explore the prognostic factors in elderly patients with unresected gastric cancer (GC) who have received chemotherapy and to develop a nomogram for predicting their cancer-specific survival (CSS). Elderly gastric cancer patients who have received chemotherapy but no surgery in the Surveillance, Epidemiology, and End Results Database between 2004 and 2015 were included in this study. Cox analyses were conducted to identify prognostic factors, leading to the formulation of a nomogram...
April 19, 2024: Scientific Reports
https://read.qxmd.com/read/38634895/electrochemotherapy-as-adjuvant-treatment-in-a-sinonasal-mucosal-melanoma-in-elderly-patient-a-case-report
#3
JOURNAL ARTICLE
Silvia Carpenè, Barbara Silvestri, Martina Bertinazzi, Enrico Armato, Maurizio Amadori, Roberto Spinato, Francesca de Terlizzi, Giuseppe Azzarello
BACKGROUND: Sinonasal Mucosal Melanoma (SNMM) is a rare but aggressive disease. Surgery with free margins, when feasible, is the treatment of choice. In the last three decades, electrochemotherapy (ECT) has emerged as a local ablative procedure, performed with the Cliniporator, for cutaneous and mucosal tumours of different histology. We present a case report of an ECT treatment performed by means of a new endoscopic electrode, on an elderly patient affected by primary SNMM. METHODS: An 88-year-old man with a diagnosis of SNMM (cT4aN0M0)-Stage IV, of the left nasal fossa presented at our institution...
April 18, 2024: European Archives of Oto-rhino-laryngology
https://read.qxmd.com/read/38616447/service-improvements-and-workload-increases-royal-college-of-radiologists-rcr-re-audit-of-curative-intent-radiotherapy-for-non-small-cell-lung-cancer-nsclc
#4
JOURNAL ARTICLE
J McAleese, K Drinkwater
AIMS: The Royal College of Radiologists (RCR) audit of radical radiotherapy (RR) for patients with non-small cell lung cancer (NSCLC) in 2013 concluded that there was under-treatment compared to international comparators and marked variability between cancer networks. Elderly patients were less likely to receive guideline recommended treatments. Access to technological developments was low. Various national and local interventions have since taken place. This study aims to re-assess national practice...
March 26, 2024: Clinical Oncology: a Journal of the Royal College of Radiologists
https://read.qxmd.com/read/38597202/bruton-s-tyrosine-kinase-btk-inhibitors-for-the-treatment-of-primary-central-nervous-system-lymphoma-pcnsl-current-progress-and-latest-advances
#5
REVIEW
Lauren Schaff, Lakshmi Nayak, Christian Grommes
The incidence of primary central nervous system lymphoma (PCNSL) has steadily increased, particularly in elderly patients. Although highly responsive to first-line chemotherapy and radiotherapy, approximately 50% of patients relapse or become refractory within 1 year. Prognosis following relapse is dismal and no standard salvage therapy exists. Bruton's tyrosine kinase (BTK), a key regulator of the B-cell receptor (BCR) pathway, has emerged as a promising therapeutic target. The first BTK inhibitor ibrutinib has been evaluated in the relapsed/refractory PCNSL setting, with overall response rates of 51...
April 10, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38579134/single-fraction-palliative-high-dose-rate-brachytherapy-for-symptom-management-in-a-97-year-old-patient-with-dementia
#6
JOURNAL ARTICLE
Ken Yoshida, Kohiro Akita, Asami Yoshida, Midori Yui, Kazuki Hirota, Hideki Takegawa, Yusuke Anetai, Yuhei Koike, Yoko Harima, Toshiko Shiga, Naomi Nakajima, Nobukata Kazawa, Atsushi Komemushi, Keita Utsunomiya, Noboru Tanigawa, Reiko Noborio, Satoaki Nakamura
Background: Delivering cancer treatment to elderly patients with dementia is often challenging. We describe performing palliative surface mold brachytherapy (SMBT) in an elderly patient with advanced dementia for pain control using music therapy to assist with agitation. Case Description: The patient was a 97-year-old Japanese woman with advanced dementia. Exudate was observed from her tumor, and she complained of Grade 2 severity pain using Support team assessment schedule (STAS), especially when undergoing would dressings...
April 5, 2024: Journal of Palliative Medicine
https://read.qxmd.com/read/38576595/high-dose-methotrexate-and-zanubrutinib-combination-therapy-for-primary-central-nervous-system-lymphoma
#7
EDITORIAL
Budhi Singh Yadav
In this editorial I comment on the article, published in the current issue of the World Journal of Clinical Oncology . Primary central nervous system lymphoma (PCNSL) is a disease of elderly and immunocompromised patients. The authors reported clinical results of 19 patients with PCNSL treated with zanubrutinib/high dose methotrexate (HD-MTX) until disease progression. They demonstrated that the combination of zanubrutinib with HD-MTX led to a marked clinical response and tolerability among these patients. They also observed that cerebrospinal fluid liquid biopsy to detect circulating tumor DNA may be a good option for evaluating treatment response and tumor burden in patients with PCNSL...
March 24, 2024: World Journal of Clinical Oncology
https://read.qxmd.com/read/38572905/cardiovascular-screening-of-elderly-athletes
#8
REVIEW
Robert Skalik, Anna Janocha
The permanently growing interest in amateur and professional sports activities among young, middle-aged and elderly athletes raises serious concerns about athletes' health, the safety of physical training, and the sports-related risk of sudden cardiac death and other cardiovascular complications during exercise. In recent years there has been an increasing number of cases of sudden cardiac death during physical effort. At present, life expectancy in the most developed countries grows rapidly and the number of people >65 years dramatically increases...
April 4, 2024: Medycyna Pracy
https://read.qxmd.com/read/38558766/pretreatment-patient-reported-overall-health-a-prognostic-factor-for-early-overall-mortality-after-primary-curative-treatment-of-prostate-cancer
#9
JOURNAL ARTICLE
Sophie D Fosså, Anne Holck Storås, Kirsti Aas, Tom Børge Johannesen, Ylva Maria Gjelsvik, Tor Å Myklebust
BACKGROUND AND OBJECTIVE: Registry-based studies for prostate cancer (PCa) document higher overall mortality (OM) after high-dose radiotherapy (RT) than after radical prostatectomy (RP). Our aim was to explore the association between pretreatment patient-reported health ("OverallHealth": OH) and curative treatment type, and the impact on early OM. METHODS: New PCa patients registered between 2017 and 2019 in the Cancer Registry of Norway ( n  = 1949) completed the European Organisation for Research and Treatment of Cancer Quality-of-Life Core 30 (QLQ-C30) questionnaire before RP ( n  = 592) or RT ( n  = 610) or after allocation to active surveillance (AS; n  = 747)...
May 2024: European urology open science
https://read.qxmd.com/read/38549381/evidence-based-clinical-recommendations-for-hypofractionated-radiotherapy-exploring-efficacy-and-safety-part-1-brain-and-head-and-neck
#10
JOURNAL ARTICLE
Soo-Yoon Sung, Jin Ho Song, Byoung Hyuck Kim, Yoo-Kang Kwak, Kyung Su Kim, Gyu Sang Yoo, Hwa Kyung Byun, Yeon Joo Kim, Yeon-Sil Kim
Advances in radiotherapy (RT) techniques, including intensity-modulated RT and image-guided RT, have allowed hypofractionation, increasing the fraction size over the conventional dose of 1.8-2.0 Gy. Hypofractionation offers advantages such as shorter treatment times, improved compliance, and under specific conditions, particularly in tumors with a low α/β ratio, higher efficacy. It was initially explored for use in RT for prostate cancer and adjuvant RT for breast cancer, and its application has been extended to various other malignancies...
March 2024: Radiation Oncology Journal
https://read.qxmd.com/read/38549336/analysis-of-the-impact-of-radiotherapy-and-surgical-treatment-regimens-based-on-the-seer-database-on-the-survival-outcomes-of-rectal-cancer-patients-over-70-years
#11
JOURNAL ARTICLE
Wei Wang, Tongping Shen, Jiaming Wang
OBJECTIVE: This study evaluates the impact of different combinations of treatment regimens, such as additional radiation, chemotherapy, and surgical treatments, on the survival of elderly rectal cancer patients ≥ 70 years of age to support physicians' clinical decision-making. METHODS: Data from a sample of elderly rectal cancer patients aged ≥ 70 years diagnosed from 2005-2015 from the US surveillance, epidemiology, and end results (SEER) database were retrospectively analyzed...
February 27, 2024: Mathematical Biosciences and Engineering: MBE
https://read.qxmd.com/read/38510578/leiomyomatous-lesions-of-the-colon-two-case-reports-with-radiological-features-pathological-correlations-and-literature-review
#12
Asma Al Hatmi, Ishaq Sulaiman Al-Salmi, Mohammed Al-Masqari, Atheel Kammona
Colonic leiomyomatous lesions are smooth muscle tumors including both benign leiomyoma and malignant leiomyosarcoma. They usually occur in elderly and middle-aged groups. They are rare, representing 3% of all gastrointestinal leiomyomas. Descending and sigmoid colon are the most commonly affected segments of colon. Patients are usually asymptomatic but occasionally they may present with abdominal pain, hemorrhage, and intestinal obstruction. Radiological findings for these lesions are variable and overlapping with other diagnoses but usually manifest as large lesions with lobulated margins, extra-colic growth, and heterogeneous enhancement...
January 2024: Oman Medical Journal
https://read.qxmd.com/read/38507145/omission-of-adjuvant-radiotherapy-in-low-risk-elderly-males-with-breast-cancer
#13
JOURNAL ARTICLE
Kim Vo, Colton Ladbury, Stephanie Yoon, Jose Bazan, Scott Glaser, Arya Amini
PURPOSE: Randomized clinical trials demonstrate that lumpectomy + hormone therapy (HT) without radiation therapy (RT) yields equivalent survival and acceptable local-regional outcomes in elderly women with early-stage, node-negative, hormone-receptor positive (HR +) breast cancer. Whether these data apply to men with the same inclusion criteria remains unknown. METHODS: The National Cancer Database was queried for male patients ≥ 65 years with pathologic T1-2N0 (≤ 3 cm) HR + breast cancer treated with breast-conserving surgery with negative margins from 2004 to 2019...
March 20, 2024: Breast Cancer: the Journal of the Japanese Breast Cancer Society
https://read.qxmd.com/read/38502258/diagnostic-and-therapeutic-considerations-in-patients-with-bilateral-diffuse-uveal-melanocytic-proliferation
#14
REVIEW
Dimitrios Kalogeropoulos, Farid Afshar, Gabriella De Salvo, Christina A Rennie, Andrew John Lotery
PURPOSE: This review aims to summarize the current knowledge concerning the clinical features, diagnostic work-up, and therapeutic approach of bilateral diffuse uveal melanocytic proliferation (BDUMP). METHODS: A meticulous literature search was performed in the PubMed database. A supplementary search was made in Google Scholar to complete the collected items. Our search strategy utilized the following keywords: "bilateral diffuse uveal melanocytic proliferation", "BDUMP", and "Paraneoplastic Syndrome"...
March 19, 2024: International Ophthalmology
https://read.qxmd.com/read/38500668/management-of-glioblastoma-in-elderly-patients-a-review-of-the-literature
#15
REVIEW
Nektarios K Mazarakis, Stephen D Robinson, Priyank Sinha, Christos Koutsarnakis, Spyridon Komaitis, George Stranjalis, Susan C Short, Paul Chumas, Georgios Giamas
High grade gliomas are the most common primary aggressive brain tumours with a very poor prognosis and a median survival of less than 2 years. The standard management protocol of newly diagnosed glioblastoma patients involves surgery followed by radiotherapy, chemotherapy in the form of temozolomide and further adjuvant temozolomide. The recent advances in molecular profiling of high-grade gliomas have further enhanced our understanding of the disease. Although the management of glioblastoma is standardised in newly diagnosed adult patients there is a lot of debate regarding the best treatment approach for the newly diagnosed elderly glioblastoma patients...
May 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38496908/glioblastoma-in-the-oldest-old-clinical-characteristics-therapy-and-outcome-in-patients-aged-80-years-and-older
#16
JOURNAL ARTICLE
Christina Stadler, Dorothee Gramatzki, Emilie Le Rhun, Andreas F Hottinger, Thomas Hundsberger, Ulrich Roelcke, Heinz Läubli, Silvia Hofer, Katharina Seystahl, Hans-Georg Wirsching, Michael Weller, Patrick Roth
BACKGROUND: Incidence rates of glioblastoma in very old patients are rising. The standard of care for this cohort is only partially defined and survival remains poor. The aims of this study were to reveal current practice of tumor-specific therapy and supportive care, and to identify predictors for survival in this cohort. METHODS: Patients aged 80 years or older at the time of glioblastoma diagnosis were retrospectively identified in 6 clinical centers in Switzerland and France...
April 2024: Neuro-oncology Practice
https://read.qxmd.com/read/38469686/protocol-of-a-randomised-controlled-trial-comparing-immediate-curative-therapy-with-conservative-treatment-in-men-aged-%C3%A2-75%C3%A2-years-with-non-metastatic-high-risk-prostate-cancer-spcg-19-grand-p
#17
JOURNAL ARTICLE
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessaether, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordstrøm, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Rannikko, Klaus Brasso
BACKGROUND: Older men (aged ≥75 years) with high risk, non-metastatic prostate cancer (PCa) are increasingly treated with curative therapy (surgery or radiotherapy). However, it is unclear if curative therapy prolongs life and improves health-related quality of life (HRQoL) in this age group compared to conservative therapy, which has evolved considerably during the last decade. STUDY DESIGN: The Scandinavian Prostate Cancer Group (SPCG) 19/Norwegian Get-Randomized Research Group-Prostate (GRand-P) is a randomised, two-armed, controlled, multicentre, phase III trial carried out at study centres in Norway, Denmark, Finland, and Sweden...
March 12, 2024: BJU International
https://read.qxmd.com/read/38439727/merkel-cell-carcinoma-of-unknown-primary-origin
#18
JOURNAL ARTICLE
Helena Francetić, Luka Simetić, Čedna Tomasović Lončarić, Daška Štulhofer Buzina, Romana Čeović
Merkel cell carcinoma (MCC) is a rare and highly aggressive primary cutaneous neuroendocrine carcinoma most often occurring in the elderly. Risk factors include chronic sun exposure and immunosuppression (1). MCC is associated with frequent recurrences and a high metastatic potential and mortality rate (1). It is the second most common cause of skin-cancer-related death after melanoma. At primary diagnosis with an apparent cutaneous tumor, loco-regional metastases are present in up to 30% of patients, and 6-12% have distant metastatic disease (2-3)...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38433231/multicenter-analysis-on-the-value-of-standard-chemo-radiotherapy-in-elderly-patients-with-locally-advanced-adenocarcinoma-of-the-esophagus-or-gastroesophageal-junction
#19
MULTICENTER STUDY
Tilman Bostel, Eirini Nikolaidou, Daniel Wollschläger, Arnulf Mayer, Justus Kaufmann, Anne Hopprich, Alexander Rühle, Anca-Ligia Grosu, Jürgen Debus, Christian Fottner, Markus Moehler, Peter Grimminger, Heinz Schmidberger, Nils Henrik Nicolay
BACKGROUND: To assess the tolerability and oncological results of chemoradiation in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction. METHODS: This multi-center retrospective analysis included 86 elderly patients (≥ 65 years) with esophageal or gastroesophageal junction adenocarcinoma (median age 73 years; range 65-92 years) treated with definitive or neoadjuvant (chemo)radiotherapy...
March 4, 2024: Radiation Oncology
https://read.qxmd.com/read/38428261/predicting-the-survival-benefit-of-radiotherapy-in-elderly-breast-cancer-patients-a-population-based-analysis
#20
JOURNAL ARTICLE
Maoxian Li, Jie Tang, Xiudan Pan, Dianlong Zhang
INTRODUCTION: This study aimed to establish two prediction tools predicting cancer-specific survival (CSS) and overall survival (OS) in elderly breast cancer patients with or without radiotherapy. METHODS: Clinicopathological data of breast cancer patients aged more than 70 y from 2010 to 2018 were retrospectively collected from the Surveillance, Epidemiology, and End Results database. Patients were randomly divided into the training and validation cohorts at 7:3, and the Cox proportional risk model was used to construct the nomograms...
February 29, 2024: Journal of Surgical Research
keyword
keyword
105116
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.